Early Access

10-QPeriod: Q3 FY2024

HCA Healthcare, Inc. Quarterly Report for Q3 Ended Sep 30, 2024

Filed October 31, 2024For Securities:HCA

Summary

HCA Healthcare, Inc. reported a strong third quarter of 2024, with revenues increasing by 7.9% to $17.487 billion and net income attributable to HCA Healthcare, Inc. rising by 17.7% to $1.270 billion ($4.88 per diluted share). This growth was driven by a combination of increased patient volumes, with equivalent admissions up 5.0%, and higher revenue per equivalent admission, up 2.8%. The company also saw a significant improvement in operating cash flow, which increased by $1.036 billion to $3.515 billion for the quarter, primarily due to favorable changes in working capital. Despite facing headwinds such as inflationary pressures on supplies and other operating expenses, and incurring approximately $50 million in losses and additional expenses related to Hurricane Helene, HCA Healthcare demonstrated resilience. The company has proactively managed labor costs, with a notable 17.8% decline in contract labor costs year-over-year. Looking ahead, HCA Healthcare anticipates further impacts from hurricanes Milton and Helene in the fourth quarter, estimated between $200 million and $300 million, but continues its strategic capital allocation through significant share repurchases and dividend payments, signaling confidence in its financial position.

Financial Statements
Beta
Revenue$17.49B
Operating Expenses$15.58B
Interest Expense$515.00M
Net Income$1.27B
EPS (Basic)$4.94
EPS (Diluted)$4.88
Shares Outstanding (Basic)256.76M
Shares Outstanding (Diluted)259.92M

Key Highlights

  • 1Revenue increased 7.9% year-over-year to $17.487 billion in Q3 2024, driven by a 5.0% rise in equivalent admissions and a 2.8% increase in revenue per equivalent admission.
  • 2Net income attributable to HCA Healthcare, Inc. grew 17.7% to $1.270 billion ($4.88 per diluted share) in Q3 2024, compared to $1.079 billion ($3.91 per diluted share) in Q3 2023.
  • 3Operating cash flow saw a substantial increase of $1.036 billion, reaching $3.515 billion in Q3 2024, largely due to improved working capital management.
  • 4The company reported a significant reduction in contract labor costs (17.8% decrease year-over-year), contributing to improved labor cost management.
  • 5HCA Healthcare incurred approximately $50 million in losses and additional expenses related to Hurricane Helene in Q3 2024, with an estimated $200-$300 million impact anticipated for Q4 2024 due to Hurricanes Helene and Milton.
  • 6Share repurchases remain a focus, with $4.949 million shares repurchased in Q3 2024 for approximately $1.79 billion, and $2.433 billion of repurchase authorization remaining as of September 30, 2024.
  • 7The company anticipates capital expenditures of approximately $5 billion for the full year 2024, with ongoing projects estimated at $4.7 billion over the next five years.

Frequently Asked Questions